Related Experiment Video
Updated: Jun 3, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
The application of molecular techniques for the study of aminoglycoside resistance
K J Shaw1, F J Sabatelli, L Naples
1Schering-Plough Research Institute, Kenilworth, NJ.
Abstract:
Aminoglycosides have been cinically used since 1944. Although this class of antibacterial agents has some nephrotoxicity and ototoxtcity issues, they continue to be part of the hospital armamentarium because of then rapid bactericidal activity, especially in combination with β-lactams. Bacterial resistance to aminoglycosides can be caused by modifying enzymes, changes in cell permeability, and changes in the cellular target. The clinical observation of high levels of aminoglycoside resistance most often results from the acquisition of genes that encode modifying enzymes and are often plasmid-borne. Aminoglycosides are inactivated by three classes of enzymes:
Insights
Aminoglycosides are vital antibiotics despite toxicity, offering rapid bacterial killing. Resistance often arises from plasmid-borne genes encoding enzymes that inactivate these crucial antibacterial agents.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Aminoglycosides have been clinically utilized since 1944.
- Despite known nephrotoxicity and ototoxicity, they remain essential in hospitals for rapid bactericidal activity, particularly with beta-lactams.
- Bacterial resistance is a growing concern, impacting treatment efficacy.
Purpose of the Study:
- To review the mechanisms of bacterial resistance to aminoglycosides.
- To highlight the clinical significance of aminoglycosides in antibacterial therapy.
- To discuss the enzymes responsible for aminoglycoside inactivation.
Main Methods:
- Literature review of aminoglycoside use and resistance mechanisms.
- Analysis of factors contributing to clinical aminoglycoside resistance.
- Categorization of aminoglycoside-inactivating enzymes.
Main Results:
- Aminoglycoside resistance is primarily driven by modifying enzymes, altered cell permeability, or target modification.
- Acquisition of plasmid-borne genes encoding modifying enzymes is a common cause of high-level resistance.
- Three main classes of enzymes are identified as responsible for aminoglycoside inactivation.
Conclusions:
- Aminoglycosides remain indispensable antibacterial agents due to their potent bactericidal effects.
- Understanding resistance mechanisms, especially enzyme-mediated inactivation, is critical for effective clinical use.
- Further research into combating aminoglycoside resistance is warranted to preserve their therapeutic value.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA
Modern Molecular Taxonomy
Applications of Molecular Taxonomy
Estimation of k and VD of Aminoglycosides
Development of Antibiotic Resistance